Effect of indinavir used alone or in double or triple combination with AZT and ddC on human immune functions

Life Sciences

Volumn 74, Issue 18, 2004, Pages 2291-2300

  Mattioli, Benedetta ^a   Giordani, Luciana ^a   Quaranta, Maria Giovanna ^a   Viora, Marina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Dideoxynucleoside analogs; HIV; Immune functions; Peripheral blood mononuclear cells; Protease inhibitor

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN; INDINAVIR; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENTIATION; DRUG USE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTOXICITY; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; UPREGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1342281644     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.09.052     Document Type: Article

References (30)

1. Andre P., Groettrup M., Klenerman P., de Giuli R., Booth B.L. Jr., Cerundolo V., Bonneville M., Jotereau F., Zinkernagel R.M., Lotteau V. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proceedings of the National Academy of Science. 95:1998;13120-13124.
2. Atzori C., Angeli E., Mainini A., Agostoni F., Micheli V., Cargnel A. In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii. Journal of Infectious Diseases. 181:2000;1629-1634.
3. Bass H.Z., Fahey J.L., Nishanian P., Detels R., Cumberland W., Kemeny M., Plaeger S. Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes. Clinical and Diagnostic Laboratory Immunology. 4:1997;64-69.
4. Deeks S.G. Determinants of virological response to antiretroviral therapy: implications for long-term strategies. Clinical Infectious Diseases. 30(Suppl. 2):2000;S177-S184.
5. D'Ettorre G., Forcina G., Andreotti M., Sarmati L., Palmisano L., Galluzzo C.M., Nicastri E., Mastroianni C.M., Vullo V., Vella S., Andreoni M. Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations. T-cell proliferation and cytokine production. AIDS. 27:2002;1877-1885.
6. Gruber A., Speth C., Lukasser-Vogl E., Zangerle R., Borg-von Zepelin M., Dierich M.P., Wurzner R. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro. Immunopharmacology. 41:1999;227-234.
7. Gruber A., Wheat J.C., Kuhen K.L., Looney D.J., Wong-Staal F. Differential effects of HIV-1 protease inhibitors on dendritic cell immunophenotype and function. Journal of Biological Chemistry. 276:2001;47840-47843.
8. Haraguchi S., Good R.A., James-Yarish M., Cianciolo G.J. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proceedings of the National Academy of Science. 92:1995;3611-3615.
9. Kaufmann D., Pantaleo G., Sudre P., Telenti A. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral and Campoli-Richard, DM. 1989 Zidovudine: A review on its pharmacodynamics and pharmacokinetic properties, and therapeutic efficacy. Drugs. 37:1998;408-450.
10. Langtry H.D., Campoli-Richards D.M. Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 37:1989;408-450.
11. Lu W., Andrieu J.M. HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism. Blood. 96:2000;250-258.
12. Lusso P., Cocchi F., Balotta C., Markham P.D., Louie A., Farci P., Pal R., Gallo R.C., Reitz M.S. Jr. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. Journal of Virology. 69:1995;3712-3720.
13. Luzzati A.L., Giacomini E., Giordani L. Evaluation of the immunotoxicity of antiretroviral drugs using an in vitro method for the induction and measurement of a specific antibody response in human peripheral blood lymphocytes. ATLA: alternatives to laboratory animals. 23:1995;191-196.
14. Miedema F., Petit A.J., Terpstra F.G., Schattenkerk J.K., de Wolf F., Al B.J., Roos M., Lange J.M., Danner S.A., Goudsmit J. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. Journal of Clincal Investestigation. 82:1988;1908-1914.
15. Noble S., Faulds D. Saquinavir. A review on its pharmacologyand clinical potential in the management of HIV infection. Drugs. 52:1996;93-112.
16. Poli G., Fauci A.S. Cytokine cascades in HIV infection. Gupta S. Immunology of HIV infection. 1997;285-301 Plenum Press, New York.
17. Quaranta M.G., Tritarelli E., Giordani L., Viora M. HIV-1 Nef induces dendritic cell differentiation: a possible mechanism of uninfected CD4+ T-cell activation. Experimental Cell Research. 275:2002;243-254.
18. Quintieri F., Viora M. Immunomodulatory effects of antiretroviral drugs on human autoreactive response. Fundamental and Clinical Immunology. 2:1994;215-221.
19. Schmidtke G., Holzhutter H.G., Bogyo M., Kairies N., Groll M., de Giuli R., Emch S., Groettrup M. How an inhibitor of the HIV-I protease modulates proteasome activity. Journal of Biological Chemistry. 274:1999;35734-35740.
20. Schmidtke G., Schmidt M., Kloetzel P.M. Maturation of mammalian 20 S proteasome: purification and characterization of 13 S and 16 S proteasome precursor complexes. Journal of Molecular Biology. 25:1997;95-106.
21. van Noesel C.J., Gruters R.A., Terpstra F.G., Schellekens P.T., van Lier R.A., Miedema F. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. Journal of Clinical Investigation. 6:1990;293-299.
22. Viora M., Camponeschi B., D'Ambrosio A., Di Carlo S., Bacosi A., Zuccaro P., Pacifici R. Zidovudine effects on murine and human immune responses. Immunology of Infectious Diseases. 4:1994;47-53.
23. Viora M., Camponeschi B., D'Ambrosio A., Di Carlo S., Zuccaro P., Pacifici R. Modulatory effects of ddC and AZT/ddC combination on murine and human immune responses. Cellular Pharmacology. 1:1994;263-268.
24. Viora M., Camponeschi B. Down-regulation of Interleukin-2 receptor gene activation and protein expression by dideoxynucleoside analogs. Cellular Immunology. 163:1995;289-295.
25. Viora M., Di Genova G., Rivabene R., Malorni W., Fattorossi A. Interference with cell cycle progression and induction of apoptosis by dideoxynucleoside analogs. Internatinal Journal of Immunopharmacology. 19:1997;311-321.
26. Viora M., Di Genova G., Quaranta M.G., Boirivant M., Camponeschi B. Lack of immunotoxicity of Saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC. Journal of Clinical Immunology. 18:1998;346-354.
27. Viora M., Giordani L., Giacomini E., Quaranta M.G. Immunomodulating effect of antiretroviral drugs. Recent Research Development in Antimicrobial Agents and Chemotherapy. 3:1999;133-151.
28. Washington C.B., Duran G.E., Man M.C., Sikic B.I., Blaschke T.F. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells. Journal of Acquired Immuno Deficiency Syndromes and Human Retrovirus. 19:1998;203-209.
29. Weichold F.F., Bryant J.L., Pati S., Barabitskaya O., Gallo R.C., Reitz M.S. Jr. HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells. Journal of Human Virology. 2:1999;261-269.
30. Wendland T., Furrer H., Vernazza P.L., Frutig K., Christen A., Matter L., Malinverni R., Pichler W.J. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. AIDS. 1:1999;1857-1862.